A tool to characterize the components of pharmacist interventions in clinical pharmacy services: The DEPICT project;Una Herramienta para Caracterizar los Componentes de las Intervenciones Farmacéuticas en los Servicios de Farmacia Clínica: El Proyecto DEPICT

Annals of Pharmacotherapy

Volumn 47, Issue 7-8, 2013, Pages 946-952

  Correr, Cassyano Januario ^a   Melchiors, Ana Carolina ^a   de Souza, Thais T ^b   Rotta, Inajara ^b   Salgado, Teresa M ^c   Fernandez Llimos, Fernando ^c  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL PHARMACY; CONCEPTUAL FRAMEWORK; DESCRIPTIVE ELEMENT OF PHARMACIST INTERVENTION CHARACTRIZATION TOOL; HUMAN; PHARMACIST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; REPRODUCIBILITY; SYSTEMATIC REVIEW (TOPIC);

EARLY MEDICAL INTERVENTION; HUMANS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84880078339     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1S006     Document Type: Article

References (31)

1. Wong ICK. Randomised controlled trials (RCTs) to evaluate complex healthcare interventions-a case study. Pharm World Sci 2004;26:247-52. doi: 10.1023/B:PHAR.0000042920.34663.04
2. Clark AM. What are the components of complex interventions in healthcare? Theorizing approaches to parts, powers and the whole intervention. Soc Sci Med. Epub 22 Apr 2012. doi: 10.1016/j.socscimed.2012.03.035
3. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: new guidance. www.mrc.ac.uk/Utilities/Documentrecord/ index.htm?d=MRC004871 (accessed 2013 Mar 28).
4. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999;33:1336-55. doi: 10.1345/aph.18440
5. Kennie NR, Schuster BG, Einarson TR. Critical analysis of the pharmaceutical care research literature (abstract). Ann Pharmacother 1998;32:17-26.
6. Melchiors AC, Correr CJ, Venson R, Pontarolo R. An analysis of quality of systematic reviews on pharmacist health interventions. Int J Clin Pharm 2012;34:32-42. doi: 10.1007/s11096-011-9592-0
7. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm 2011;68:241-53. doi: 10.2146/ajhp090656
8. Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 2011;171:1441-53. doi: 10.1001/archinternmed.2011.399
9. Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother 2009;43:1096-106. doi: 10.1345/aph.1L700
10. Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transplant 2012;27:276-92. doi: 10.1093/ndt/gfr287
11. Charrois TL, Durec T, Tsuyuki RT. Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating results. Ann Pharmacother 2009;43:118-22. doi: 10.1345/aph.1L302
12. Weinberger M, Oddone EZ, Henderson WG, et al. Multisite randomized controlled trials in health services research: scientific challenges and operational issues. Med Care 2001;39:627-34. doi: 10.1097/00005650-200106000-00010
13. Higgins JPT Green S, eds. Cochrane handbook for systematic reviews of interventions, version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011.
14. Collins C, Limone BL, Scholle JM, Coleman CI. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract 2011; 92:145-52. doi: 10.1016/j.diabres.2010.09.023
15. Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care 2010;48:923-33. doi: 10.1097/MLR.0b013e3181e57962
16. Medical Research Council. A framework for development and evaluation of RCTs for complex inerventions to improve health. www.mrc.ac.uk/ Utilities/Documentrecord/index.htm?d=MRC003372 (accessed 2012 Jul 18).
17. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309.
18. Mohler R, Bartoszek G, Kopke S, Meyer G. Proposed criteria for reporting the development and evaluation of complex interventions in healthcare (CReDECI): guideline development. Int J Nurs Stud 2012;49:40-6. doi: 10.1016/j.ijnurstu.2011.08.003
19. Lamb SE, Becker C, Gillespie LD, et al. Reporting of complex interventions in clinical trials: development of a taxonomy to classify and describe fall-prevention interventions. Trials 2011;12:125. doi: 10.1186/1745-6215-12-125
20. Campbell M. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-6. doi: 10.1136/bmj.321.7262.694
21. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. doi: 10.1136/bmj.b2535
22. Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 2005;85:257-68. http:// ptjournal.apta.org/content/85/3/257.long (accessed 2013 Mar 28).
23. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
24. Evans CD, Watson E, Eurich DT, et al. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review. Ann Pharmacother 2011;45:615-28. doi: 10.1345/aph.1P615
25. Benavides S, Rodriguez JC, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother 2009;43:85-97. doi: 10.1345/aph.1K612
26. Shepperd S, Lewin S, Straus S, et al. Can we systematically review studies that evaluate complex interventions? PLoS Med 2009;6:e1000086. doi: 10.1371/journal.pmed.1000086
27. Holland R, Lenaghan E, Harvey I, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005;330:293. doi: 10.1136/bmj.38338.674583.AE
28. Zermansky AGG, Petty DRR, Raynor DKK, Freemantle N, Vail A, Lowe CJJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001;323:1340-3. doi: 10.1136/bmj.323.7325.1340
29. Mackie CA, Lawson DH, Maclaren AG, Kaczorowski JSJ. A randomised controlled trial of medication review in patients receiving polypharmacy in general practice. Pharm J 1999;263: R7.
30. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001;30:205-11. doi: 10.1093/ageing/30.3.205
31. Petty D, Raynor T, Zermansky A, Alldred D, Bowie P, Freemantle N. HOMER trial was not a clinical medication review. www.bmj.com/rapidresponse/ 2011/10/30/homer-trial-was-not-clinical-medication-review (accessed 2013 Mar 28).